Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 313570, 16 pages
http://dx.doi.org/10.1155/2014/313570
Review Article

Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms

1Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, University of Catania, Viale A. Doria 6, 95125 Catania, Italy
2Department of “G.F. Ingrassia”, Section of Hygiene and Public Health, University of Catania, Via S. Sofia 85, 95123 Catania, Italy
3Department of Educational Sciences, University of Catania, Via Teatro Greco 84, 95124 Catania, Italy
4IRCCS Associazione Oasi Maria S.S.-Institute for Research on Mental Retardation and Brain Aging, Via Conte Ruggiero 73, Enna, 94018 Troina, Italy

Received 7 June 2013; Accepted 7 February 2014; Published 18 March 2014

Academic Editor: Ryuichi Morishita

Copyright © 2014 Giuseppe Grosso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. P. Simopoulos, “The importance of the ratio of omega-6/omega-3 essential fatty acids,” Biomedicine and Pharmacotherapy, vol. 56, no. 8, pp. 365–379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. N. Din, D. E. Newby, and A. D. Flapan, “Omega 3 fatty acids and cardiovascular disease—fishing for a natural treatment,” British Medical Journal, vol. 328, no. 7430, pp. 30–35, 2004. View at Google Scholar · View at Scopus
  3. K. Walters, G. Rait, M. Griffin, M. Buszewicz, and I. Nazareth, “Recent trends in the incidence of anxiety diagnoses and symptoms in primary care,” PLoS ONE, vol. 7, no. 8, Article ID e41670, 2012. View at Google Scholar
  4. A. P. Simopoulos, “Executive summary of the international conference on genetic variation and nutrition,” World Review of Nutrition and Dietetics, vol. 63, pp. 1–13, 1990. View at Google Scholar · View at Scopus
  5. A. P. Simopoulos and J. Ordovas, Nutrigenetics and Nutrigenomics, vol. 93, Karger, Washington, DC, USA, 2004.
  6. A. P. Simopoulos, “Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases,” Biomedicine and Pharmacotherapy, vol. 60, no. 9, pp. 502–507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Sinclair, D. Begg, M. Mathai, and R. S. Weisinger, “Omega 3 fatty acids and the brain: review of studies in depression,” Asia Pacific Journal of Clinical Nutrition, vol. 16, supplement 1, pp. 391–397, 2007. View at Google Scholar · View at Scopus
  8. C. J. Murray and A. D. Lopez, “Global mortality, disability, and the contribution of risk factors: global burden of disease study,” The Lancet, vol. 349, no. 9063, pp. 1436–1442, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Rivelli and W. Jiang, “Depression and ischemic heart disease: what have we learned from clinical trials?” Current Opinion in Cardiology, vol. 22, no. 4, pp. 286–291, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. World Health Organization, The Global Burden of Disease: 2004 Update, World Health Organization, Geneva, Switzerland, 2008.
  11. R. C. Kessler, P. Berglund, O. Demler et al., “The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R),” Journal of the American Medical Association, vol. 289, no. 23, pp. 3095–3105, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Andrade, J. J. Caraveo-Anduaga, P. Berglund et al., “The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys,” International Journal of Methods in Psychiatric Research, vol. 12, no. 1, pp. 3–21, 2003. View at Google Scholar
  13. D. S. Hasin, R. D. Goodwin, F. S. Stinson, and B. F. Grant, “Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions,” Archives of General Psychiatry, vol. 62, no. 10, pp. 1097–1106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. B. Patten, “Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low,” BMC Psychiatry, vol. 9, article 19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. World Health Organization, A Public Health Approach to Mental Health, World Health Organization, Geneva, Switzerland, 2001.
  16. P. Sobocki, B. Jönsson, J. Angst, and C. Rehnberg, “Cost of depression in Europe,” Journal of Mental Health Policy and Economics, vol. 9, no. 2, pp. 87–98, 2006. View at Google Scholar · View at Scopus
  17. J. Tiihonen, J. Lonnqvist, K. Wahlbeck et al., “No mental health without physical health,” The Lancet, vol. 377, no. 9766, p. 611, 2011. View at Google Scholar
  18. M. Prince, V. Patel, S. Saxena et al., “No health without mental health,” The Lancet, vol. 370, no. 9590, pp. 859–877, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Sanchez-Villegas and M. A. Martinez-Gonzalez, “Diet, a new target to prevent depression?” BMC Medicine, vol. 11, article 3, 2013. View at Publisher · View at Google Scholar
  20. R. Machado-Vieira and A. G. Mallinger, “Abnormal function of monoamine oxidase-A in comorbid major depressive disorder and cardiovascular disease: pathophysiological and therapeutic implications (review),” Molecular Medicine Reports, vol. 6, no. 5, pp. 915–922, 2012. View at Google Scholar
  21. D. P. Do, J. Beam Dowd, N. Ranjit, J. S. House, and G. A. Kaplan, “Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults,” Psychosomatic Medicine, vol. 72, no. 7, pp. 613–619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. W. E. Severus, A. B. Littman, and A. L. Stoll, “Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder,” Harvard Review of Psychiatry, vol. 9, no. 6, pp. 280–293, 2001. View at Google Scholar · View at Scopus
  23. H. Ito, R. Kawashima, S. Awata et al., “Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique,” Journal of Nuclear Medicine, vol. 37, no. 3, pp. 410–414, 1996. View at Google Scholar · View at Scopus
  24. T. A. Kimbrell, T. A. Ketter, M. S. George et al., “Regional cerebral glucose utilization in patients with a range of severities of unipolar depression,” Biological Psychiatry, vol. 51, no. 3, pp. 237–252, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. N. J. Stapelberg, D. L. Neumann, D. H. K. Shum, H. McConnell, and I. Hamilton-Craig, “A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease,” Australian and New Zealand Journal of Psychiatry, vol. 45, no. 5, pp. 351–369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. B. K. Puri, “Cardiovascular disease and depression: the PUFA connection,” International Journal of Clinical Practice, vol. 62, no. 3, pp. 355–357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. H. Cui, N. Petrovic, and M. Murray, “The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation,” British Journal of Pharmacology, vol. 162, no. 5, pp. 1143–1155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Pifferi, M. Jouin, J. M. Alessandri et al., “n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 77, no. 5-6, pp. 279–286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Pifferi, M. Jouin, J. M. Alessandri et al., “N-3 long-chain fatty acids and regulation of glucose transport in two models of rat brain endothelial cells,” Neurochemistry International, vol. 56, no. 5, pp. 703–710, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. X. Da Silva, F. Lavialle, G. Gendrot, P. Guesnet, J.-M. Alessandri, and M. Lavialle, “Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids,” Journal of Neurochemistry, vol. 81, no. 6, pp. 1328–1337, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Pifferi, F. Roux, B. Langelier et al., “(n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats,” Journal of Nutrition, vol. 135, no. 9, pp. 2241–2246, 2005. View at Google Scholar · View at Scopus
  32. A. P. Simopoulos, “The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases,” Experimental Biology and Medicine, vol. 233, no. 6, pp. 674–688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. R. Hibbeln and N. Salem Jr., “Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy,” The American Journal of Clinical Nutrition, vol. 62, no. 1, pp. 1–9, 1995. View at Google Scholar · View at Scopus
  34. T. L. Blasbalg, J. R. Hibbeln, C. E. Ramsden, S. F. Majchrzak, and R. R. Rawlings, “Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century,” The American Journal of Clinical Nutrition, vol. 93, no. 5, pp. 950–962, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, “Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease,” Circulation, vol. 106, no. 21, pp. 2747–2757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. World Health Organization, “Diet, nutrition and the prevention of chronic diseases,” Report of the Joint WHO/FAO Expert Consultation, World Health Organization, Geneva, Switzerland, 2003. View at Google Scholar
  37. National Health Medical Research Council, Nutrient Reference Values for Australia and New Zealand Including Recommended Dietary Intakes, NHMRC, 2006.
  38. A. Tanskanen, J. R. Hibbeln, J. Tuomilehto et al., “Fish consumption and depressive symptoms in the general population in Finland,” Psychiatric Services, vol. 52, no. 4, pp. 529–531, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Bountziouka, E. Polychronopoulos, A. Zeimbekis et al., “Long-term fish intake is associated with less severe depressive symptoms among elderly men and women: the MEDIS (MEDiterranean ISlands Elderly) epidemiological study,” Journal of Aging and Health, vol. 21, no. 6, pp. 864–880, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Timonen, D. Horrobin, J. Jokelainen, J. Laitinen, A. Herva, and P. Räsänen, “Fish consumption and depression: the Northern Finland 1966 birth cohort study,” Journal of Affective Disorders, vol. 82, no. 3, pp. 447–452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. L. Suominen-Taipale, T. Partonen, A. W. Turunen, S. Männistö, A. Jula, and P. K. Verkasalo, “Fish consumption and omega-3 polyunsaturated fatty acids in relation to depressive episodes: a cross-sectional analysis,” PLoS ONE, vol. 5, no. 5, Article ID e10530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. K. M. Appleton, J. V. Woodside, J. W. G. Yarnell et al., “Depressed mood and dietary fish intake: direct relationship or indirect relationship as a result of diet and lifestyle?” Journal of Affective Disorders, vol. 104, no. 1–3, pp. 217–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Murakami, Y. Miyake, S. Sasaki, K. Tanaka, and M. Arakawa, “Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus child health study,” Pediatrics, vol. 126, no. 3, pp. e623–e630, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Li, Q. Dai, L. I. Ekperi, A. Dehal, and J. Zhang, “Fish consumption and severely depressed mood, findings from the first national nutrition follow-up study,” Psychiatry Research, vol. 190, no. 1, pp. 103–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Sanchez-Villegas, P. Henríquez, A. Figueiras, F. Ortuño, F. Lahortiga, and M. A. Martínez-González, “Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study,” European Journal of Nutrition, vol. 46, no. 6, pp. 337–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Astorg, A. Couthouis, S. Bertrais et al., “Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-aged French men and women,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 78, no. 3, pp. 171–182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Noaghiul and J. R. Hibbeln, “Cross-national comparisons of seafood consumption and rates of bipolar disorders,” The American Journal of Psychiatry, vol. 160, no. 12, pp. 2222–2227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. Food and Agriculture Organization of the United Nations, Consumption of Fish and Fishery Products, 2001, http://www.fao.org/fishery/statistics/global-consumption/en.
  49. T. N. Akbaraly, S. Sabia, M. J. Shipley, G. D. Batty, and M. Kivimaki, “Adherence to healthy dietary guidelines and future depressive symptoms: evidence for sex differentials in the Whitehall II study,” The American Journal of Clinical Nutrition, vol. 97, no. 2, pp. 419–427, 2013. View at Google Scholar
  50. T. N. Akbaraly, E. J. Brunner, J. E. Ferrie, M. G. Marmot, M. Kivimaki, and A. Singh-Manoux, “Dietary pattern and depressive symptoms in middle age,” British Journal of Psychiatry, vol. 195, no. 5, pp. 408–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. F. N. Jacka, P. J. Kremer, M. Berk et al., “A prospective study of diet quality and mental health in adolescents,” PLoS ONE, vol. 6, no. 9, Article ID e24805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. F. N. Jacka, A. Mykletun, M. Berk, I. Bjelland, and G. S. Tell, “The association between habitual diet quality and the common mental disorders in community-dwelling adults: the hordaland health study,” Psychosomatic Medicine, vol. 73, no. 6, pp. 483–490, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. F. N. Jacka, J. A. Pasco, A. Mykletun et al., “Association of western and traditional diets with depression and anxiety in women,” The American Journal of Psychiatry, vol. 167, no. 3, pp. 305–311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. K. A. Skarupski, C. C. Tangney, H. Li, D. A. Evans, and M. C. Morris, “Mediterranean diet and depressive symptoms among older adults over time,” The Journal of Nutrition Health and Aging, vol. 17, no. 5, pp. 441–445, 2013. View at Google Scholar
  55. A. Sánchez-Villegas, M. Delgado-Rodríguez, A. Alonso et al., “Association of the Mediterranean dietary pattern with the incidence of depression: The Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort,” Archives of General Psychiatry, vol. 66, no. 10, pp. 1090–1098, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Rienks, A. J. Dobson, and G. D. Mishra, “Mediterranean dietary pattern and prevalence and incidence of depressive symptoms in mid-aged women: results from a large community-based prospective study,” European Journal of Clinical Nutrition, vol. 67, no. 1, pp. 75–82, 2013. View at Google Scholar
  57. A. Hodge, O. P. Almeida, D. R. English, G. G. Giles, and L. Flicker, “Patterns of dietary intake and psychological distress in older Australians: benefits not just from a Mediterranean diet,” International Psychogeriatrics, vol. 25, no. 3, pp. 456–466, 2013. View at Google Scholar
  58. M. Luciano, R. Mottus, J. M. Starr et al., “Depressive symptoms and diet: their effects on prospective inflammation levels in the elderly,” Brain, Behavior, and Immunity, vol. 26, no. 5, pp. 717–720, 2012. View at Google Scholar
  59. G. Antonogeorgos, D. B. Panagiotakos, C. Pitsavos et al., “Understanding the role of depression and anxiety on cardiovascular disease risk, using structural equation modeling, the mediating effect of the Mediterranean diet and physical activity: the ATTICA study,” Annals of Epidemiology, vol. 22, no. 9, pp. 630–637, 2012. View at Google Scholar
  60. A. Sánchez-Villegas, P. Henríquez, M. Bes-Rastrollo, and J. Doreste, “Mediterranean diet and depression,” Public Health Nutrition, vol. 9, no. 8, pp. 1104–1109, 2006. View at Google Scholar · View at Scopus
  61. J. Sontrop, W. R. Avison, S. E. Evers, K. N. Speechley, and M. K. Campbell, “Depressive symptoms during pregnancy in relation to fish consumption and intake of n-3 polyunsaturated fatty acids,” Paediatric and Perinatal Epidemiology, vol. 22, no. 4, pp. 389–399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Murakami, T. Mizoue, S. Sasaki et al., “Dietary intake of folate, other B vitamins, and ω-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults,” Nutrition, vol. 24, no. 2, pp. 140–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. W. H. Oddy, S. Hickling, M. A. Smith et al., “Dietary intake of omega-3 fatty acids and risk of depressive symptoms in adolescents,” Depression and Anxiety, vol. 28, no. 7, pp. 582–588, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. K. M. Appleton, T. J. Peters, R. C. Hayward et al., “Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association?” Social Psychiatry and Psychiatric Epidemiology, vol. 42, no. 2, pp. 100–104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. D. B. Panagiotakos, E. Mamplekou, C. Pitsavos et al., “Fatty acids intake and depressive symptomatology in a greek sample: an epidemiological analysis,” Journal of the American College of Nutrition, vol. 29, no. 6, pp. 586–594, 2010. View at Google Scholar · View at Scopus
  66. L. A. Colangelo, K. He, M. A. Whooley, M. L. Daviglus, and K. Liu, “Higher dietary intake of long-chain ω-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women,” Nutrition, vol. 25, no. 10, pp. 1011–1019, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Hakkarainen, T. Partonen, J. Haukka, J. Virtamo, D. Albanes, and J. Lönnqvist, “Is low dietary intake of omega-3 fatty acids associated with depression?” The American Journal of Psychiatry, vol. 161, no. 3, pp. 567–569, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. F. N. Jacka, J. A. Pasco, M. J. Hensry, M. A. Kotowicz, G. C. Nicholson, and M. Berk, “Dietary omega-3 fatty acids and depression in a community sample,” Nutritional Neuroscience, vol. 7, no. 2, pp. 101–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Kyrozis, T. Psaltopoulou, P. Stathopoulos, D. Trichopoulos, D. Vassilopoulos, and A. Trichopoulou, “Dietary lipids and geriatric depression scale score among elders: the EPIC-Greece cohort,” Journal of Psychiatric Research, vol. 43, no. 8, pp. 763–769, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Strøm, E. L. Mortensen, T. I. Halldorsson, I. Thorsdottir, and S. F. Olsen, “Fish and long-chain n-3 polyunsaturated fatty acid intakes during pregnancy and risk of postpartum depression: a prospective study based on a large national birth cohort,” The American Journal of Clinical Nutrition, vol. 90, no. 1, pp. 149–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Golding, C. Steer, P. Emmett, J. M. Davis, and J. R. Hibbeln, “High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish,” Epidemiology, vol. 20, no. 4, pp. 598–603, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. C. M. M. Da Rocha and G. Kac, “High dietary ratio of omega-6 to omega-3 polyunsaturated acids during pregnancy and prevalence of post-partum depression,” Maternal and Child Nutrition, vol. 8, no. 1, pp. 36–48, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Lucas, F. Mirzaei, E. J. O'Reilly et al., “Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study,” The American Journal of Clinical Nutrition, vol. 93, no. 6, pp. 1337–1343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. E. Kesse-Guyot, M. Touvier, V. A. Andreeva et al., “Cross-sectional but not longitudinal association between n-3 fatty acid intake and depressive symptoms: results from the SU.VI.MAX 2 study,” The American Journal of Epidemiology, vol. 175, no. 10, pp. 979–987, 2012. View at Google Scholar
  75. Y. Li, J. Zhang, and R. E. McKeown, “Cross-sectional assessment of diet quality in individuals with a lifetime history of attempted suicide,” Psychiatry Research, vol. 165, no. 1-2, pp. 111–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Nanri, T. Mizoue, K. Poudel-Tandukar et al., “Dietary patterns and suicide in Japanese adults: the Japan Public Health Center-based Prospective Study,” The British Journal of Psychiatry, vol. 203, no. 6, pp. 422–427, 2013. View at Google Scholar
  77. J. Zhang, Y. Li, and M. E. Torres, “How does a suicide attempter eat differently from others? Comparison of macronutrient intakes,” Nutrition, vol. 21, no. 6, pp. 711–717, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. K. Poudel-Tandukar, A. Nanri, M. Iwasaki et al., “Long chain n-3 fatty acids intake, fish consumption and suicide in a cohort of Japanese men and women—the Japan public health center-based (JPHC) prospective study,” Journal of Affective Disorders, vol. 129, no. 1–3, pp. 282–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. M. P. Freeman, J. R. Hibbeln, K. L. Wisner et al., “Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry,” Journal of Clinical Psychiatry, vol. 67, no. 12, pp. 1954–1967, 2006. View at Google Scholar · View at Scopus
  80. P. Y. Lin and K. P. Su, “A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids,” Journal of Clinical Psychiatry, vol. 68, no. 7, pp. 1056–1061, 2007. View at Google Scholar · View at Scopus
  81. K. M. Appleton, R. C. Hayward, D. Gunnell et al., “Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials,” The American Journal of Clinical Nutrition, vol. 84, no. 6, pp. 1308–1316, 2006. View at Google Scholar · View at Scopus
  82. P. J. Rogers, K. M. Appleton, D. Kessler et al., “No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial,” British Journal of Nutrition, vol. 99, no. 2, pp. 421–431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Y. Lin, D. Mischoulon, M. P. Freeman et al., “Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression,” Molecular Psychiatry, vol. 17, no. 12, pp. 1161–1163, 2012. View at Google Scholar
  84. B. M. Ross, J. Seguin, and L. E. Sieswerda, “Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?” Lipids in Health and Disease, vol. 6, article 21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. J. G. Martins, “EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials,” Journal of the American College of Nutrition, vol. 28, no. 5, pp. 525–542, 2009. View at Google Scholar · View at Scopus
  86. M. E. Sublette, S. P. Ellis, A. L. Geant, and J. J. Mann, “Meta-analysis of the effects of Eicosapentaenoic Acid (EPA) in clinical trials in depression,” Journal of Clinical Psychiatry, vol. 72, no. 12, pp. 1577–1584, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. R. Massart, R. Mongeau, and L. Lanfumey, “Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression,” Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, vol. 367, no. 1601, pp. 2485–2494, 2012. View at Google Scholar
  88. P. C. Calder, P. Yaqoob, D. J. Harvey, A. Watts, and E. A. Newsholme, “Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity,” Biochemical Journal, vol. 300, no. 2, pp. 509–518, 1994. View at Google Scholar · View at Scopus
  89. C. R. Lee and M. W. Hamm, “Effect of dietary fat and cholesterol supplements on glucagon receptor binding and adenylate cyclase activity of rat liver plasma membrane,” Journal of Nutrition, vol. 119, no. 4, pp. 539–546, 1989. View at Google Scholar · View at Scopus
  90. S. N. Ahmad, B. S. Alma, and S. Q. Alam, “Dietary omega-3 fatty acids increase guanine nucleotide binding proteins and adenylate cyclase activity in rat salivary glands,” The FASEB Journal, vol. 3, article A948, 1989. View at Google Scholar
  91. R. A. Bowen and M. T. Clandinin, “Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats,” Journal of Neurochemistry, vol. 83, no. 4, pp. 764–774, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. V. V. Vaidyanathan, K. V. Rao, and P. S. Sastry, “Regulation of diacylglycerol kinase in rat brain membranes by docosahexaenoic acid,” Neuroscience Letters, vol. 179, no. 1-2, pp. 171–174, 1994. View at Publisher · View at Google Scholar · View at Scopus
  93. J. J. Mann and K. M. Malone, “Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients,” Biological Psychiatry, vol. 41, no. 2, pp. 162–171, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. J. R. Hibbeln, M. Linnoila, J. C. Umhau, R. Rawlings, D. T. George, and N. Salem Jr., “Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late- onset alcoholics,” Biological Psychiatry, vol. 44, no. 4, pp. 235–242, 1998. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Vines, A. M. Delattre, M. M. S. Lima et al., “The role of 5-HT1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism,” Neuropharmacology, vol. 62, no. 1, pp. 184–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Delion, S. Chalon, D. Guilloteau, J.-C. Besnard, and G. Durand, “α-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex,” Journal of Neurochemistry, vol. 66, no. 4, pp. 1582–1591, 1996. View at Google Scholar · View at Scopus
  97. R. K. McNamara, J. Able, Y. Liu et al., “Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects,” Journal of Psychiatric Research, vol. 43, no. 6, pp. 656–663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. R. K. McNamara, R. Jandacek, T. Rider, P. Tso, A. Cole-Strauss, and J. W. Lipton, “Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 83, no. 4–6, pp. 185–191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. C. A. Heidbreder, I. C. Weiss, A. M. Domeney et al., “Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome,” Neuroscience, vol. 100, no. 4, pp. 749–768, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Zangen, D. H. Overstreet, and G. Yadid, “Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment,” Brain Research, vol. 824, no. 2, pp. 243–250, 1999. View at Publisher · View at Google Scholar · View at Scopus
  101. L. Zimmer, S. Vancassel, S. Cantagrel et al., “The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids,” The American Journal of Clinical Nutrition, vol. 75, no. 4, pp. 662–667, 2002. View at Google Scholar · View at Scopus
  102. L. Zimmer, S. Delion-Vancassel, G. Durand et al., “Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids,” Journal of Lipid Research, vol. 41, no. 1, pp. 32–40, 2000. View at Google Scholar · View at Scopus
  103. S. Chalon, S. Delion-Vancassel, C. Belzung et al., “Dietary fish oil affects monoaminergic neurotransmission and behavior in rats,” Journal of Nutrition, vol. 128, no. 12, pp. 2512–2519, 1998. View at Google Scholar · View at Scopus
  104. N. Müller and M. J. Schwarz, “The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression,” Molecular Psychiatry, vol. 12, no. 11, pp. 988–1000, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. Q.-S. Yan, M. E. A. Reith, P. C. Jobe, and J. W. Dailey, “Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats,” Brain Research, vol. 765, no. 1, pp. 149–158, 1997. View at Publisher · View at Google Scholar · View at Scopus
  106. P. Martin, M. L. Carlsson, and S. Hjorth, “Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats,” NeuroReport, vol. 9, no. 13, pp. 2985–2988, 1998. View at Google Scholar · View at Scopus
  107. A. Latour, B. Grintal, G. Champeil-Potokar et al., “Omega-3 fatty acids deficiency aggravates glutamatergic synapse and astroglial aging in the rat hippocampal CA1,” Aging Cell, vol. 12, no. 1, pp. 76–84, 2013. View at Google Scholar
  108. B. Grintal, G. Champeil-Potokar, M. Lavialle, S. Vancassel, S. Breton, and I. Denis, “Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid,” Neurochemistry International, vol. 54, no. 8, pp. 535–543, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. J. D. Moreira, L. Knorr, M. Ganzella et al., “Omega-3 fatty acids deprivation affects ontogeny of glutamatergic synapses in rats: relevance for behavior alterations,” Neurochemistry International, vol. 56, no. 6-7, pp. 753–759, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. L. A. Speizer, M. J. Watson, and L. L. Brunton, “Differential effects of omega-3 fish oils on protein kinase activities in vitro,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 261, no. 1, pp. E109–E114, 1991. View at Google Scholar · View at Scopus
  111. O. Holian and R. Nelson, “Action of long-chain fatty acids on protein kinase C activity: comparison of omega-6 and omega-3 fatty acids,” Anticancer Research, vol. 12, no. 3, pp. 975–980, 1992. View at Google Scholar · View at Scopus
  112. C. L. Raison and A. H. Miller, “When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders,” The American Journal of Psychiatry, vol. 160, no. 9, pp. 1554–1565, 2003. View at Publisher · View at Google Scholar · View at Scopus
  113. T. W. W. Pace, F. Hu, and A. H. Miller, “Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression,” Brain, Behavior, and Immunity, vol. 21, no. 1, pp. 9–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. O. J. G. Schiepers, M. C. Wichers, and M. Maes, “Cytokines and major depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 29, no. 2, pp. 201–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Hennebelle, L. Balasse, A. Latour et al., “Influence of omega-3 fatty acid status on the way rats adapt to chronic restraint stress,” PLoS ONE, vol. 7, no. 7, Article ID e42142, 2012. View at Google Scholar
  116. A. C. Ferraz, A. M. Delattre, R. G. Almendra et al., “Chronic ω-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol,” Behavioural Brain Research, vol. 219, no. 1, pp. 116–122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. C. Song, X. Li, B. E. Leonard, and D. F. Horrobin, “Effects of dietary n-3 or n-6 fatty acids on interleukin-1β-induced anxiety, stress, and inflammatory responses in rats,” Journal of Lipid Research, vol. 44, no. 10, pp. 1984–1991, 2003. View at Publisher · View at Google Scholar · View at Scopus
  118. H. Murck, C. Song, D. F. Horrobin, and M. Uhr, “Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression,” International Journal of Neuropsychopharmacology, vol. 7, no. 3, pp. 341–349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. F. Holsboer, “The corticosteroid receptor hypothesis of depression,” Neuropsychopharmacology, vol. 23, no. 5, pp. 477–501, 2000. View at Publisher · View at Google Scholar · View at Scopus
  120. A. M. Karssen, O. C. Meijer, I. C. J. van der Sandt et al., “Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain,” Endocrinology, vol. 142, no. 6, pp. 2686–2694, 2001. View at Publisher · View at Google Scholar · View at Scopus
  121. C. M. Pariante, A. Makoff, S. Lovestone et al., “Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters,” British Journal of Pharmacology, vol. 134, no. 6, pp. 1335–1343, 2001. View at Google Scholar · View at Scopus
  122. C. M. Pariante and A. H. Miller, “Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment,” Biological Psychiatry, vol. 49, no. 5, pp. 391–404, 2001. View at Publisher · View at Google Scholar · View at Scopus
  123. B. L. Mason and C. M. Pariante, “The effects of antidepressants on the hypothalamic-pituitary-adrenal axis,” Drug News and Perspectives, vol. 19, no. 10, pp. 603–608, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. C. Navarro, I. González-Álvarez, M. González-Álvarez et al., “Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model,” European Journal of Pharmaceutical Sciences, vol. 42, no. 3, pp. 290–299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  125. F. Caraci, A. Copani, F. Nicoletti, and F. Drago, “Depression and Alzheimer's disease: neurobiological links and common pharmacological targets,” European Journal of Pharmacology, vol. 626, no. 1, pp. 64–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  126. V. Krishnan and E. J. Nestler, “Linking molecules to mood: new insight into the biology of depression,” The American Journal of Psychiatry, vol. 167, no. 11, pp. 1305–1320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. K. Wager-Smith and A. Markou, “Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?” Neuroscience and Biobehavioral Reviews, vol. 35, no. 3, pp. 742–764, 2011. View at Publisher · View at Google Scholar · View at Scopus
  128. M. Maes, R. Yirmyia, J. Noraberg et al., “The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression,” Metabolic Brain Disease, vol. 24, no. 1, pp. 27–53, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. A.-M. Myint, B. E. Leonard, H. W. M. Steinbusch, and Y.-K. Kim, “Th1, Th2, and Th3 cytokine alterations in major depression,” Journal of Affective Disorders, vol. 88, no. 2, pp. 167–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  130. V. H. Perry, C. Cunningham, and C. Holmes, “Systemic infections and inflammation affect chronic neurodegeneration,” Nature Reviews Immunology, vol. 7, no. 2, pp. 161–167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. S. L. Tilley, T. M. Coffman, and B. H. Koller, “Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes,” Journal of Clinical Investigation, vol. 108, no. 1, pp. 15–23, 2001. View at Publisher · View at Google Scholar · View at Scopus
  132. P. M. Kidd, “Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids,” Alternative Medicine Review, vol. 12, no. 3, pp. 207–227, 2007. View at Google Scholar · View at Scopus
  133. P. C. Calder, “n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases,” The American Journal of Clinical Nutrition, vol. 83, supplement 6, pp. S1505–S1519, 2006. View at Google Scholar
  134. M. Peet, B. Murphy, J. Shay, and D. Horrobin, “Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients,” Biological Psychiatry, vol. 43, no. 5, pp. 315–319, 1998. View at Publisher · View at Google Scholar · View at Scopus
  135. R. Edwards, M. Peet, J. Shay, and D. Horrobin, “Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients,” Journal of Affective Disorders, vol. 48, no. 2-3, pp. 149–155, 1998. View at Publisher · View at Google Scholar · View at Scopus
  136. M. Maes, A. Christophe, J. Delanghe, C. Altamura, H. Neels, and H. Y. Meltzer, “Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients,” Psychiatry Research, vol. 85, no. 3, pp. 275–291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  137. P. B. Adams, S. Lawson, A. Sanigorski, and A. J. Sinclair, “Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression,” Lipids, vol. 31, supplement 3, pp. S157–S161, 1996. View at Google Scholar · View at Scopus
  138. M. Maes, R. Smith, A. Christophe, P. Cosyns, R. Desnyder, and H. Meltzer, “Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids,” Journal of Affective Disorders, vol. 38, no. 1, pp. 35–46, 1996. View at Publisher · View at Google Scholar · View at Scopus
  139. H. Tiemeier, H. R. van Tuijl, A. Hofman, A. J. Kiliaan, and M. M. B. Breteler, “Plasma fatty acid composition and depression are associated in the elderly: The Rotterdam Study,” The American Journal of Clinical Nutrition, vol. 78, no. 1, pp. 40–46, 2003. View at Google Scholar · View at Scopus
  140. J. K. Kiecolt-Glaser, M. A. Belury, K. Porter, D. Q. Beversdorf, S. Lemeshow, and R. Glaser, “Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults,” Psychosomatic Medicine, vol. 69, no. 3, pp. 217–224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. A. M. Rizzo, P. A. Corsetto, G. Montorfano et al., “Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters,” Nutrition Journal, vol. 11, article 82, 2012. View at Publisher · View at Google Scholar
  142. A. M. Rees, M. P. Austin, C. Owen, and G. Parker, “Omega-3 deficiency associated with perinatal depression: case control study,” Psychiatry Research, vol. 166, no. 2-3, pp. 254–259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. A. Schins, H. J. Crijns, R.-J. M. Brummer et al., “Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients,” Acta Psychiatrica Scandinavica, vol. 115, no. 1, pp. 35–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. N. Frasure-Smith, F. Lespérance, and P. Julien, “Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes,” Biological Psychiatry, vol. 55, no. 9, pp. 891–896, 2004. View at Publisher · View at Google Scholar · View at Scopus
  145. G. B. Parker, G. A. Heruc, T. M. Hilton et al., “Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression,” Psychiatry Research, vol. 141, no. 3, pp. 279–286, 2006. View at Publisher · View at Google Scholar · View at Scopus
  146. M. E. Sublette, J. R. Hibbeln, H. Galfalvy, M. A. Oquendo, and J. J. Mann, “Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk,” The American Journal of Psychiatry, vol. 163, no. 6, pp. 1100–1102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  147. S. Riemer, M. Maes, A. Christophe, and W. Rief, “Lowered ω-3 PUFAs are related to major depression, but not to somatization syndrome,” Journal of Affective Disorders, vol. 123, no. 1–3, pp. 173–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. G. Mamalakis, M. Tornaritis, and A. Kafatos, “Depression and adipose essential polyunsaturated fatty acids,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 67, no. 5, pp. 311–318, 2002. View at Publisher · View at Google Scholar · View at Scopus
  149. G. Mamalakis, N. Kalogeropoulos, N. Andrikopoulos et al., “Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete,” European Journal of Clinical Nutrition, vol. 60, no. 7, pp. 882–888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  150. G. Mamalakis, E. Jansen, H. Cremers, M. Kiriakakis, G. Tsibinos, and A. Kafatos, “Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids in the survivors of the seven countries study population of Crete,” European Journal of Clinical Nutrition, vol. 60, no. 8, pp. 1016–1023, 2006. View at Publisher · View at Google Scholar · View at Scopus
  151. G. Mamalakis, M. Kiriakakis, G. Tsibinos et al., “Lack of an association of depression with n-3 polyunsaturated fatty acids in adipose tissue and serum phospholipids in healthy adults,” Pharmacology Biochemistry and Behavior, vol. 89, no. 1, pp. 6–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. G. Mamalakis, M. Kiriakakis, G. Tsibinos, and A. Kafatos, “Depression and adipose polyunsaturated fatty acids in an adolescent group,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 71, no. 5, pp. 289–294, 2004. View at Publisher · View at Google Scholar · View at Scopus
  153. M. Wichers and M. Maes, “The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans,” International Journal of Neuropsychopharmacology, vol. 5, no. 4, pp. 375–388, 2002. View at Publisher · View at Google Scholar · View at Scopus
  154. Y. Dowlati, N. Herrmann, W. Swardfager et al., “A meta-analysis of cytokines in major depression,” Biological Psychiatry, vol. 67, no. 5, pp. 446–457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  155. P. C. Calder, “N-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions,” Proceedings of the Nutrition Society, vol. 72, no. 3, pp. 326–336, 2013. View at Google Scholar
  156. D. Y. Lu, Y. Y. Tsao, Y. M. Leung, and K. P. Su, “Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids,” Neuropsychopharmacology, vol. 35, no. 11, pp. 2238–2248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  157. Y. Park, H. J. Moon, and S. H. Kim, “N-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test,” Journal of Nutritional Biochemistry, 2011. View at Publisher · View at Google Scholar · View at Scopus
  158. A. Moranis, J. C. Delpech, V. de Smedt-Peyrusse et al., “Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice,” Brain, Behavior, and Immunity, vol. 26, no. 5, pp. 721–731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  159. C. N. Serhan, “Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 8, no. 2, pp. 115–121, 2005. View at Google Scholar · View at Scopus
  160. A. A. Farooqui, L. A. Horrocks, and T. Farooqui, “Modulation of inflammation in brain: a matter of fat,” Journal of Neurochemistry, vol. 101, no. 3, pp. 577–599, 2007. View at Publisher · View at Google Scholar · View at Scopus
  161. S. M. Prescott and W. F. Stenson, “Fish oil fix,” Nature Medicine, vol. 11, no. 6, pp. 596–598, 2005. View at Publisher · View at Google Scholar · View at Scopus
  162. Y. Kim and C. Lee, “The gene encoding transforming growth factor β1 confers risk of ischemic stroke and vascular dementia,” Stroke, vol. 37, no. 11, pp. 2843–2845, 2006. View at Publisher · View at Google Scholar · View at Scopus
  163. L. Sutcigil, C. Oktenli, U. Musabak et al., “Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy,” Clinical and Developmental Immunology, vol. 2007, Article ID 76396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  164. P. Vollmar, A. Haghikia, R. Dermietzel, and P. M. Faustmann, “Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model,” International Journal of Neuropsychopharmacology, vol. 11, no. 1, pp. 111–117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  165. M. Hida, H. Fujita, K. Ishikura, S. Omori, M. Hoshiya, and M. Awazu, “Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-β in mesangial cells,” Journal of Cellular Physiology, vol. 196, no. 2, pp. 293–300, 2003. View at Publisher · View at Google Scholar · View at Scopus
  166. A. Thienprasert, S. Samuhaseneetoo, K. Popplestone, A. L. West, E. A. Miles, and P. C. Calder, “Fish oil n-3 polyunsaturated fatty acids selectively affect plasma cytokines and decrease illness in Thai schoolchildren: a randomized, double-blind, placebo-controlled intervention trial,” Journal of Pediatrics, vol. 154, no. 3, pp. 391–395, 2009. View at Publisher · View at Google Scholar · View at Scopus